Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Bergamot may improve heart health, skin conditions, and mood, but more research is needed to confirm these benefits.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Accurate method measures finasteride levels in human plasma using gas chromatography-mass spectrometry.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

CAP1/Prss8 does not activate PAR2 or inhibit PN-1.

Newborns with the common rash Erythema Toxicum have many active mast cells in their skin, but these cells don't produce the LL-37 peptide.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Nail loss may be a side effect of the MS drug teriflunomide.

RSPO1 mutations in certain patients lead to skin cells that don't develop properly and are more likely to become invasive, increasing the risk of skin cancer.

Both classical and L-type atypical BSE from cattle can infect goats with different incubation times, and tests can distinguish between the two strains.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Current treatments for androgenetic alopecia are often ineffective and have side effects, needing better options.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Surgery can be a safe and effective option for infertile women with PCOS who don't respond to medication and want to get pregnant.

Low education and income can lead to not following high blood pressure treatment.

A man with skin and hair symptoms improved partially with specific treatment.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

COVID-19 may cause hair loss conditions like alopecia areata and telogen effluvium.

Different types of skin cells create unique support structures that can affect skin cell growth and could help in skin repair.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.